Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers
NCT ID: NCT04525417
Last Updated: 2021-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2020-04-25
2020-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
An open-label, monocentric, prospective, non-randomized study, is conducted, including 50 hospital healthcare professionals and 50 private health professionals.
Knowledge of serostatus will achieve the implementation of a strategy of management of patients according to specific immunity of health professionals
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers
NCT04445415
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820
Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test
NCT04904510
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra
NCT05172167
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hospital healthcare workers
Clinical examination; Veinous blood sampling for serological testing; capillary drawing to perform a rapid Covid-19 test
AAZ Covid-19 rapid test
To assess the immune status
private health professionals
Clinical examination; Veinous blood sampling for serological testing; capillary drawing to perform a rapid Covid-19 test
AAZ Covid-19 rapid test
To assess the immune status
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AAZ Covid-19 rapid test
To assess the immune status
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnant women
* protected adult
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisabeth Bouvet, MD
Role: PRINCIPAL_INVESTIGATOR
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bichat University Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID RCB 2020-A01031-38
Identifier Type: OTHER
Identifier Source: secondary_id
GERES20200409
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.